The UK Animal Genetics Market was valued at $132.81 Million in 2024 and projected to reach to $177.47 Million by 2029, representing a compound annual growth rate of 6.0%. The UK animal genetics market is positioned for sustained growth driven by intensifying demand for improved livestock productivity and efficiency.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The UK animal genetics market reached $132.81 million in 2024, with projections to grow to $177.47 million by 2029, reflecting steady expansion in the domestic sector.
UK farmers increasingly adopt advanced selective breeding programs to enhance livestock productivity, supported by the nation's established agricultural infrastructure and breeding heritage.
Advances in genomic testing technologies are transforming UK animal breeding practices, enabling more precise genetic selection and disease resistance identification across cattle, sheep, and poultry.
The UK's robust regulatory framework and post-Brexit agricultural policies create a favorable environment for innovation in animal genetics and breeding technologies.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | OTHER TECHNOLOGIES (Technology) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 7.1% from 2024 to 2029 |
| Largest Segment | ANIMAL GENETIC MATERIALS (Product & Service) |
| Market Size Base Year (Billions) | ~USD 2.97 (2024) |
| Revenue Forecast (Billions) | ~USD 4.19 (2029) |
| Segments Covered | Animal Type, Product & Service, Type, Live Animal, Technology, End User |
6 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ANIMAL FARMS | 76 | 82.1 | 88 | 93.6 | 99.4 | 105.6 | 112.5 | 121.6 | 6.7 |
| DIAGNOSTIC CENTERS | 46.2 | 50.1 | 53.9 | 57.6 | 61.4 | 65.4 | 70 | 76 | 7.1 |
| RESEARCH INSTITUTES | 1.7 | 1.8 | 1.9 | 2 | 2.1 | 2.2 | 2.3 | 2.5 | 5.5 |
| VETERINARY HOSPITALS & CLINICS | 31.6 | 33.9 | 36.1 | 38.1 | 40.1 | 42.3 | 44.8 | 48 | 5.9 |
| TOTAL | 155.5 | 167.8 | 179.9 | 191.2 | 203.1 | 215.5 | 229.6 | 248.1 | 6.6 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables (stabilization, purification kits, secondary consumables),Immune response (IGRA TB, transplant, viral load),Oncology and sexual/reproductive health assays, |
| NEOGEN CORPORATION | United States | Public Company | Food Safety test kits and consumables,Food Safety software, media, and lab services,Animal Safety instruments, disposables, and animal care products, |
| GENUS PLC | United Kingdom | Public Company | Genus PIC (pork genetics and semen),Genus ABS (dairy and beef semen and embryos),Genus Research and Development, |
| GENETIC TECHNOLOGIES LIMITED | Australia | Public Company | GeneType oncology risk tests (breast, colorectal, ovarian, prostate, pancreatic, melanoma),Non-oncology polygenic risk tests (coronary artery disease, type 2 diabetes, atrial fibrillation),Consumer and lifestyle genetic testing (EasyDNA, AffinityDNA), |
| ZOETIS, INC. | United States | Public Company | Companion animal pharmaceuticals (parasiticides, dermatology, pain, other),Livestock pharmaceuticals and vaccines,Diagnostics (point-of-care, instruments, reference labs), |
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company is a major player in the life sciences and diagnostics industry.
NEOGEN CORPORATION is a United States public company founded in 1981 with 2,974 employees. The company operates in the genetics and life sciences sector.
GENUS PLC is a United Kingdom public company founded in 1994 with 3,190 employees. The company specializes in animal genetics and breeding solutions.
GENETIC TECHNOLOGIES LIMITED is an Australian public company founded in 1987 with 55 employees. The company operates in the genetic testing and diagnostics field.
ZOETIS, INC. is a United States public company founded in 2012 with 14,500 employees. The company is a leading global provider of animal health products and services.
The UK animal genetics market was valued at $132.81 million in 2024 and is projected to reach $177.47 million by 2029.
The UK animal genetics market is expected to grow at a compound annual growth rate (CAGR) of 6.0% from 2024 to 2029.
The UK market is driven by demand across dairy, beef, poultry, and aquaculture sectors, all seeking improved productivity and genetic selection.
Genomic testing, artificial intelligence in breeding programs, and precision farming technologies are key innovations driving UK market growth.
The UK's strong regulatory framework and animal welfare standards encourage adoption of genetic technologies to improve sustainability and food security.
Secondary research was conducted to gather information for this technical, market-oriented, and commercial study of the global animal genetics market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Different approaches, such as top-down and bottom-up, were used to estimate the total market size. After that, market breakup and data triangulation procedures were used to estimate the size of the segments and subsegments of the animal genetics market.
In the secondary research process, various secondary sources were consulted to identify and collect information for the study. These sources included annual reports, press releases, and investor presentations; regulatory filings; clinical literature and peer-reviewed journals; related association publications; certified publications; and white papers. Secondary research was primarily used to obtain key information on the industry's supply chain, the total pool of key players, market classification and segmentation according to industry trends down to the most granular level, regional markets, and key developments from both market- and technology-oriented perspectives. Primary sources further validated all this information.
In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included CEOs, vice presidents, business development directors, marketing directors, R&D heads, genomics specialists, breeding program managers, and other key executives from companies operating in the animal genetics market. Primary sources from the demand side included livestock producers, breeding organizations, veterinarians, veterinary surgeons, diagnostic laboratories, research institutes, universities, and government organizations involved in animal breeding and genetic improvement. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into industry trends, technological advancements, and market dynamics.
In the market engineering process, top-down and bottom-up approaches were extensively used, along with multiple data triangulation methods, to estimate and forecast the overall market as well as its segments and subsegments. Extensive qualitative and quantitative analyses were conducted throughout the market engineering process to provide comprehensive market estimates and strategic insights.
Following the market engineering process, including market size estimation, forecasting, market breakdown, and data triangulation, extensive primary research was conducted to verify and validate the final market estimates. Primary interviews were also used to confirm the market segmentation, competitive landscape, adoption of genomic and reproductive technologies, regional trends, and key market dynamics, including drivers, restraints, opportunities, challenges, and strategic developments within the animal genetics market.

Note 1: Others include veterinarians, breeding managers, livestock producers, genomics specialists, and diagnostic laboratory professionals
Note 2: Tier 1 companies – revenue higher than USD 10 billion; Tier 2 companies – revenue between USD 1 and 10 billion; Tier 3 companies – revenue between USD 500 million and USD 1 billion.
Note 3: The breakup above represents an indicative list of primary profiles.
To know about the assumptions considered for the study, download the pdf brochure
Top-down and bottom-up approaches were used to estimate and validate the size of the animal genetics market and the sizes of various dependent subsegments within the overall market. The research methodology used to estimate market size includes the following: key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This procedure included reviewing the annual and financial reports of the top market players, along with extensive interviews with key industry leaders, such as CEOs, VPs, directors, and marketing executives, to gain key insights.
All percentage splits and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, examined in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data is consolidated and combined with detailed input and analysis from MarketsandMarkets.

After determining the overall market size using the market size estimation processes explained above, the market was segmented into several segments and subsegments. Data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for each market segment and subsegment. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
The animal genetics market comprises products, services, and technologies used to improve the genetic characteristics of livestock and companion animals through selective breeding, assisted reproductive technologies, and molecular genetics. The market includes genetic materials, such as semen, embryos, and ova, along with genetic testing services including disease susceptibility testing, genetic trait testing, parentage verification, breed identification, DNA typing, and genomic analysis. It also encompasses enabling technologies such as Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Recombinant DNA (rDNA) technology, microarrays, SNP genotyping, microsatellite (STR) analysis, and Sanger sequencing, which facilitate genetic evaluation and selection. These products and services are used across bovine, porcine, poultry, aquaculture, equine, canine, feline, ovine, caprine, and other animal species by animal farms, veterinary hospitals & clinics, diagnostic centers, and research institutes to enhance productivity, fertility, disease resistance, product quality, and the long-term sustainability of animal breeding programs.
With the given market data, MarketsandMarkets offers customizations based on company-specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Animal Genetics Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report